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Introduction 
Background 
The issue of cannabis use amongst people with schizophrenia is well-established.  
After reviewing 35 studies Koskinen et al. (2009) concluded that approximately 
25% of people with schizophrenia met the criteria for cannabis use disorder.  Up 
to 50% of people with schizophrenia use illicit substances (DoH, 2002), often 
referred to as ‘dual diagnosis’.  Kipping (2004) defined dual diagnosis as the co-
existence of mental health and substance use.   
Studies by the US and the UK by Bartels et al (2006) and Fahmy et al (2012) 
respectively point out that dual diagnosis is an area of growing public health 
concern with few research or treatment options. Whilst there have been 
advances in the medicines available to treat people with schizophrenia, 
professionals, patients and society are not necessarily seeing the benefits 
because of non-adherence with medication, disengagement and substance misuse 
all compromising the effectiveness of treatment (Benaiges et al., 2013).  In many 
different countries, mental health professionals have to contend with poor 
medication compliance; poor physical health; poor self-care; increased suicide 
risk, and aggression as barriers to adequately treating dual diagnosis service 
users (Buckley, 2006; Munro & Edward, 2008; Padwa et al., 2013; Di Lorenzo et 
al., 2014; Borges et al., 2016).  In comparison to those people with schizophrenia 
who do not use cannabis, dual diagnosis service users have a higher prevalence 
of:   homelessness; worsening of psychiatric symptoms; poor medication 
compliance; HIV infection rates; contact with the criminal justice system; 
markedly increased use of institutional mental health services (DoH, 2002, 
Manrique-Garcia et al., 2014).  A Canadian study by Kalant (2004) concluded 
that regular cannabis use contributes to poorer psychosocial outcomes for 
schizophrenic service users.  Similarly, a US study (Bahorik et al., 2013) 
established that substance use amongst people with schizophrenia is a frequent 
and long-term problem, which interferes with the individual’s potential recovery.   
 
A systematic review conducted in Spain by Gomez Perez et al (2014) found that 
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the most common reasons for cannabis use in patients with psychosis were 
related to social activities, mood disturbances and relaxation. Gregg et al (2007) 
reviewed the self-report literature into the reasons for the high prevalence of 
substance use amongst people with schizophrenia despite the poorer outcomes. 
Aside from demographic factors and contextual factors, such as a family history 
of substance use, the strongest theory why substance misuse co-morbidity 
develops in people with schizophrenia was self-medication; using substances to 
mitigate against the unpleasant mood effects and for the “alleviation of 
dysphoria”.  A finding of Graham and Maslin (2002) was that key workers 
believed pleasure enhancement and coping strategies were the primary reasons 
for cannabis use in people with schizophrenia.   
 
Childs et al. (2011) investigated the experiences of people with psychosis who 
used cannabis. Whilst the participants in that study were younger than the 
service user participants in this study they reported positive benefits to 
cannabis. The main finding of Childs et al. (2011) was that cannabis use was a 
journey where experiences of cannabis changed across time and this journey also 
included negative experiences; including losing all motivation as a consequence 
of smoking cannabis. A South African study by Parshotam and Joubert (2015) 
examined the views of schizophrenic patients about the effects of cannabis on 
their mental health and found that participants responded that cannabis helped 
reduce tension, reduce anxiety, lift their mood, relax, relieve boredom, feel more 
energetic, sleep better, reduce auditory hallucinations, and a significant minority 
believed that the beneficial effects of cannabis outweighed its negative effects. 
 
Wilson (2008) reports that there is limited research into the experiences and 
motivations behind cannabis use and Koskinen et al. (2009) highlighted it is 
important to report research findings into substance use in the schizophrenia 
population as this influences other research areas.   
This paper reports on a finding regarding the perceptions of cannabis use from 
the perspective of service users and clinicians to seek greater understanding of 
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the experiences of people who had severe mental health problems (SMHP) and a 
history of disengagement from mental health services. 
Design & Methods 
Research Questions 
Table 1 {Research questions in the larger study} 
This research reports on findings from a part of a larger study (Wagstaff et al, 
2016) which was conducted among people affected by SMHP with an history of 
disengagement from mental health services. A research question of the larger 
study sought to understand, from the perspective of both service users and 
clinicians, cannabis use within the experience of men people with a diagnosis of 
schizophrenia (Table 1) 
The study was a cross-sectional interpretative study design, with a qualitative 
approach. The development of the aim and objectives for the study was an 
iterative process combining reading the literature on the subject, discussion 
within the research team, responding to comments from the ethics committee 
and also professional intuition.   
There were two components to the larger study; study 1 consisted of was 
individual semi-structured interviews with seven male service users who 
described their ethnic identity as ‘black’, had a diagnosis of schizophrenia and a 
history of disengagement from mental health services (Wagstaff et al, 2016). 
Study 2 involved two focus groups with clinicians who worked in Assertive 
Outreach teams in the West Midlands, UK (under review).  This paper reports 
on findings from both study components of the study. 
Whilst IPA is traditionally used with single participants there is precedent of 
IPA being adapted to suit the focus group research design (under review, Palmer 
et al, 2010, Tomkins & Eatough, 2010).  Whilst IPA celebrates the generation of 
unique, interpretative findings of individual experiences, using group interviews 
could potentially make it harder to develop detailed narratives of a specific 
phenomenon (Palmer et al., 2010). However there is precedence to demonstrate 
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that using IPA to analyse focus group data should generate a singular socially 
constructed narrative, providing detail and depth (Green and Thorogood, 2014).    
Participants and recruitment  
The service user participants were recruited by the researcher meeting with 
Assertive Outreach Teams (AOTs) and explaining the research, from where team 
members acted as ‘gatekeepers’ and introduced the researcher to potential 
participants.  The process of collaborative working with the AOTs echoes 
Abrams’ (2010) successful work of building connections with gatekeepers as a 
means to access ‘hard-to-reach’ populations. Taylor and Kearney (2005) and 
Rooney et al. (2012) have respectively highlighted that differences in the ethnic 
identity between researchers and the participants and also when participants 
are drug users could prove to be barriers to recruitment onto research studies.  
However, in this instance these barriers proved surmountable and the model for 
recruiting participants proved successful.   
During the recruitment phase of study 1 effective working relationships were 
established with local AOTs and the same teams were approached when 
recruiting participants for study 2.   
Purposive sampling was used in both phases of the study; participants were 
deliberately recruited for their unique ability to address the research question.  
The inclusion criteria for the participants in study 1 was a diagnosis of 
schizophrenia,described their racial identity as ‘black’ had a history of 
disengagement from mental health services and used cannabis.  The inclusion 
criteria for the participants in study 2 was that they were a clinician working for 
an AOT. 
 
Table 2 {Interview schedule} 
Data collection 
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The semi structured interviews in study 1 were performed in the service user’s 
homes and the focus groups in study 2 were carried out at both the team’s base 
and at the researcher’s university.  In both study 1 and 2 the research interviews 
were digitally recorded and transcribed.   
In study 1 the research interviews followed a semi-structured interview informed 
by the aim and objectives of the study.  However, as fieldwork developed the 
questions were also informed by ideas expressed by the previous participants. 
In study 2 the focus groups followed a semi-structured interview informed by the 
aim and objectives of the study and sought the clinician’s interpretation of the 
themes generated in study 1.  The focus groups were facilitated by two 
researchers, one who asked questions to the group and ensured that there was a 
calm atmosphere throughout and another who noted the subtleties of 
interaction, e.g. facial expressions and body language.  Each focus group lasted 
about an hour and between the two focus groups there were twelve participants.  
In both focus groups the team leaders participated in the study.   
Data analysis 
Qualitative research, and associated sampling techniques, are not concerned 
with achieving representativeness (Barbour & Barbour, 2002).  A modified 
interpretative phenomenological analysis (IPA) research method was designed as 
an appropriate method to study the phenomena under investigation, primarily 
because it allowed for close examination of the individual service users’ 
experience and for the researcher to interpret and accurately reflect on the 
experiences of service users from the most informed position possible.  An aim of 
using IPA to analyse the focus group data was to generate a singular socially 
constructed narrative regarding the clinicians’ understanding of the role of 
cannabis in the lived experience of men with schizophrenia.  As Watts and 
Priebe (2002) have previously argued, the use of phenomenological analysis 
allows for the examination of the differing perspectives in community psychiatry 
and recognises that there are different levels of explanation for such a complex 
phenomenon as disengagement.   
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The data analysis process was as reflexive and as participatory as possible; 
including levels of interpretations from the study supervisors, the clarifying 
interviews, a research diary and, in the service user stage, input from service 
user reviewers. The final interpretation rested with the researcher.  Further 
details of the research methods can be found in (Wagstaff & Wiliams, 2014) and 
(under review). 
Both stages of the study were reviewed, and given approval, by both the local 
research committee (BENS - 11/H1206/2) and the researcher’s institution’s ethics 
committee (ERN_13-0093).  The research participants chose their own 
pseudonyms. 
Findings 
An interpretative theme that emerged from study 1 was that the participants 
believed cannabis was a means by which they were able to reinforce their 
personal resilience and promote a more positive identity for themselves; this was 
a theme where the participants placed great meaning and emphasis.  Whilst 
both crack cocaine and alcohol were also used by the study 1 participants it was 
only cannabis that the participants reported as an important substance capable 
of bringing beneficial effects to users.   In study 2 participants recognised this 
phenomenon and had adapted their clinical practice accordingly, which is 
discussed further under theme 4.   
Below is a chart of the participant’s characteristics. 
Table 3 {Study 1 participant characteristics} 
Six of the study 1 participants reported using cannabis and the seventh (Rebel) 
said he had not used cannabis since he was at school, yet he praised cannabis 
and he had cannabis paraphernalia around his flat.  Three participants also used 
alcohol but did not speak about it’s benefits and similarly Clue and Black Zee 
used both cannabis and crack cocaine but did not talk of the benefits of using the 
latter.  The study 1 participants had been using cannabis for a long time and are 
part of a growing group of over the age of 55 dual diagnosis service users about 
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whom there is limited research.  Given the age of the participants and the 
absence of early clinical notes, details of their cannabis are unclear.  One 
participant was 64 at the time of the interview and said he had started smoking 
cannabis before he left Jamaica aged 13.  Another participant was in his 50s and 
had been using cannabis since his late teens.  The older participants were being 
admitted to hospital less frequently, were no longer committing violent crimes or 
serving prison terms, had accommodation and were able to give perspective on 
their life course. 
The participants cited a number of different reasons and benefits to their 
cannabis use; fitting in with their local community, becoming closer to God, 
experiencing a little happiness, lifting misery, creativity, relaxation, enjoyment, 
way of life, identity, pain control, being good for your health, straightening the 
mind, helping with the voices, medicinal cure, making you conscious of things 
you want to be conscious of and sleeping.   
Four themes were identified related to the benefits of cannabis use:  Identity; 
Conceptions of physical health; Mental well-being and enjoyment; Part of 
everyday life. These themes allowed us to understand that the use of cannabis in 
the life experience of men diagnosed with schizophrenia was the contribution of 
cannabis in their lives. 
1. Identity 
Central to the experience of using cannabis was the contribution cannabis made 
in forming an identity, with Clue going as far as to say that,  
“Drugs make you the man you are”.   
This quote comes in the context of Clue was discussing his faith in God, the 
rights of people and the right to be happy and also reflecting upon lessons whilst 
he had learned from being in prison.  When discussing these divergent ideas 
Clue felt that throughout his lived experience he had come to believe that 
cannabis added to his character and identity.  Josh cites that, in addition to 
other benefits of cannabis use, it also contributed significantly to his personality:  
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“it’s all to do with my person that makes me, if I smoke that it makes that 
person who I am become, people become friendly with you because there’s a lot of 
people smoke those things and do those things, you know, and they’re more 
friendly with you”.   
Josh took this a stage further, not only was cannabis a component of his identity 
but also others too.  According to him smoking cannabis allowed him to, 
“... I can feel the vibration of people, but it’s people, people” 
Whilst Josh was clear that cannabis was much part of his identity he also 
realised that his identity as a cannabis smoker this was one of the factors that 
was used to stop him from seeing his children.  The participants only felt 
benefits from using cannabis and none highlighted any negative consequences of 
use or concerns about the legal status of cannabis.  Their comments suggest that 
cannabis was prevalent throughout the communities in which they live and part 
of normal life.  Again linking cannabis use to identity Bubbles said,  
“Have a drink and a smoke, I’m just normal.  I’m just normal”  
Some of the service users commented on their position within society; with the 
pervasive sentiment being that cannabis helped them belong more within their 
community.  However, despite Bubbles explaining that through his use of 
cannabis (and alcohol) he is able to feel as if he is just a normal member of his 
community, he also said three times himself and others were going, “Nowhere”. 
2. Conceptions of physical health 
The conceptions of the study 1 participants was that cannabis helped with 
physical illnesses. However, they could not explain this help and neither the 
physical conditions.  In Arthur’s opinion,  
“I have had my prostate gland removed. ... And I used to have bowel cancer 
... So marijuana helps it you know.  [researcher:  Did it help with the pain 
control?]  Yes, yes”.   
At the time of the interview Clue had emphysema, it was of note that he said, 
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“... I like cannabis... it’s good for your lungs as well.  It’s herbs”.  
T recognised that cannabis may not solely be good for his health and 
emphasising his ambivalence towards his physical health T said,  
“I choose to ignore the bad part and I choose to smoke it and enjoy it and 
not think about its harming my health”.   
Without being able to explain why there was a sense amongst the study 1 
participants that the use of cannabis was good for their physical health. 
 
3. Mental health and enjoyment 
The study 1 participants' conceptions of cannabis use also related to mental 
health and pleasure, attributing therapeutic effects.  Arthur and T compared the 
effects of cannabis to the effects of medication.  When asked about the 
relationship between hearing voices and smoking marijuana, Arthur said,  
“Make it better and injection makes it better.  The injection sort of 
straightens the mind, you know? ... And cannabis straightens the mind.  
[researcher: So cannabis and the injection do the same?]  Yes, it straightens the 
mind”  
Also T replied,  
“Cannabis would make you sleep. ... And the medication doesn’t”.   
Whilst Clue was dismissive of the effects of psychotropic medication he 
understood the benefits of cannabis on the symptoms of his schizophrenia:  
“[cannabis] keep the voices down ... Yeah, they keep the voices away from 
me”.   
Whereas Bubbles felt that he benefitted from cannabis because of the impact on 
his prevailing sense of sorrow:  
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“Being weak and depressed and down and out, like I am.  Just miserable.  
That’s why I smoke to get me out of my misery”.   
Additionally Bubbles also said, 
 “I just have a little spliff now and then, that just calms me down and sorts 
my mind out.” 
Josh’s experience though was more generalised, that cannabis helped him with 
his thinking:  
“When I smoke weed I feel like it’s a knowledgeable being helped to me, it 
makes me see things clearly .... clearly and helpful”. 
Simplistically the participants expressed that they enjoyed the experience of 
smoking cannabis, for example Clue said, 
“ ... taking drugs to me it’s a way of life. ... I enjoy drugs yeah, weed and 
crack”  
Returning to the theme of moving from a sense of misery to a sense of mental 
well-being, Bubbles said,  
“I just get high and just have a bit of enjoyment in life”. 
Rebel said that he had not smoked cannabis since school, and he is exceptional 
amongst the participants in that he did not smoke.  Yet, despite not smoking, he 
certainly was not condemning it and praised its value:  
“Herb is a medicine, it is a plant which is a green plant and it is a medicine 
and it’s written in the Bible.  It is used as a medicine for creativity, it’s 
creation”. 
4. Drugs are part of everyday life 
The study 1 participants only felt benefits from using cannabis and none 
highlighted any negative consequences of use or concerns about the legal status 
of cannabis. Their comments suggest that cannabis was prevalent throughout 
the communities in which they live and part of normal life.  When this theme 
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was raised in the focus groups, in study 2, there was broad agreement, reflecting 
clinical experience.  The clinicians acknowledged that they had to work alongside 
their service users’ drug use and that it was part of the lives of the people on 
their caseload.  For instance Pat said,  
“…we have no control what cannabis they smoke or what they don’t, 
regardless of what the research and information says.  We can advise and 
educate and give information but we can’t stop them smoking cannabis; 
that’s a personal choice of theirs”. 
The clinicians were willing to work with people who are using cannabis and did 
not necessarily see cannabis use as problematic.  Both focus groups said that 
they would neither encourage someone to smoke cannabis nor tell anyone that 
they had to stop.  They fully recognised that they had to respond to each person’s 
attitude to cannabis differently and respect their right to individual treatment.  
As Bernard said,  
“It’s about understanding that some people can take humungous amounts 
of weed ... it does not really affect them too much mentally.  It might make 
them lethargic and less gregarious but some people have just got good 
tolerance levels and other people haven’t.  And just because someone has 
got psychosis doesn’t mean to say that they’ve got an intolerance to 
cannabis as well, which may be quite a useful thing to understand, because 
your approach has to be individual.” 
Slightly contradicting the views of the clinicians Black Zee questioned that given 
cannabis was so prevalent within the community why were professionals trying 
to stop people from using it:  
“It is everywhere, isn’t it, it was everyone.  I am not sure, but the thing is 
‘What are they trying to get rid of?’ is my question”.   
However, the clinicians also took a different attitude towards crack cocaine than 
they did towards cannabis.  Despite the strides taken to offer individualised care, 
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the clinicians were wary about the impact of crack cocaine on people’s lives.  
Again it was Bernard who said,  
“It attracts them down a route of crime and prostitution and needing 
money.  The harsher comedown and the people they mix with maybe a 
harder group of people than your friend around the corner who sells you a 
bit of weed.  It drives you into the darker underbelly of the community”. 
Fitting in with the sentiment expressed by Black Zee – “It is everywhere, isn’t it” 
– the issue of criminality or the legal implications of the substance use was not 
an issue that either the service user or clinicians participants raised.  The 
conceptions of the clinicians in study 2 showed that they tolerate the use of 
cannabis, do not report on the harms of this consumption.   
DISCUSSION 
The objective of this paper was to understand the role of cannabis use in the 
lived experience of people with schizophrenia.  The study 1 participants 
expressed the conception that in their experience cannabis use was everyday life 
(as with others in their community), promoted a more positive identity as well as 
benefits in physical and mental health and providing more enjoyment to their 
lives. The clinicians also recognized that it was part of everyday life for their 
service users and as such recognised that they needed to tolerate it’s use.  Whilst 
the service users all tended to speak positively of cannabis use, such sentiments 
run contrary to much research literature. 
Reflecting on this study and the work of Drake et al (2006), Blank et al (2016),  
Chorlton & Smith (2016) a theme that becomes apparent is that there is a strong 
sense that through the use of cannabis by people with schizophrenia are able to 
develop a feeling of belonging and social inclusion.   
A study by Drake et al. (2006) on recovery for people with co-occurring 
schizophrenia and substance use disorders over a ten-year period who achieved 
some stability, felt more control over the symptoms of their schizophrenia, 
substance abuse was in remission, most were living independently, some were 
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employed, some had regular contact with non-substance users and most had 
overall life satisfaction.  Phillips and Johnson (2001) examined different aspects 
of dual diagnosis and suggested that there is some evidence that people with 
schizophrenia use cannabis to reduce general dysphoria, and possibly negative 
symptoms. It is unclear whether these findings match the experiences of the 
service users in this study who tended to frame their experiences positively, 
smoking cannabis to bring happiness, relaxation and to feel normal. That is not 
to say that if the service users had been asked they would have responded that 
without cannabis they would have felt greater levels of sadness, anxiety and 
isolation from society. 
Blank et al (2016) discussed the different dimensions of belonging for people with 
mental health and substance misuse problems.  They concluded that there was a 
role for mental health professionals to play in enabling service users to develop 
embodied feelings of belonging through promoting relaxation.  Additionally, 
Blank et al (2016) also encourage mental health professionals to consider the 
language used in the discussion of belonging and that each invidual will have an 
idiosyncratic interpretation of what belonging means. 
The literature review by Chorlton & Smith (2016) suggest that the motivations 
of people with mental health problems to use substances reflect both their social 
circumstances and complex psychological processes.  Similar to this study some 
of the benefits of substance of substance use was found to be that enabled 
development of alternative identities and social inclusion.  For Chorlton & Smith 
(2016) the goal would be for professionals to work with service users to achieve 
these goals without resorting to substance use. 
With reference to the role that cannabis plays in the development identity within 
their local community for people with schizophrenia both Robertson (2009) and 
McDonough and Walters (2001) discussed an understanding human behaviour in 
modern society through role theory.  In role theory the social expectations of a 
person in relation to their social status produces conformity to that perceived 
role, typically through family relations or work.  Societal expectations encourage 
fulfilment of these roles through a range of implicit or explicit rewards and 
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sanctions, which usually facilitates conformity (Parsons and Bale, 1956).  In the 
context of this study the service users were living outside of conventional roles 
and expectations for men in living in modern UK society yet there was the 
retention of the idea that there was a social norm to which they expected 
themselves to conform to.  The service users were all long term users of mental 
health services, all saw cannabis use as beneficial, most had been in prison, all 
were long term unemployed.  Thus despite living unconventional lives there was 
a powerful sense of wanting to belong within a particular social context.  Pleck 
(1995) spoke of Male Gender Role Strain, not being able to conform to 
traditionally ascribed social expectations, by conforming to different levels of 
social expectations these service users did not feel this strain.   
Jenkins (2000) argued that individuals partly construct their identity out of the 
conflict between different boundaries of their multiple possible identities.  For 
Jenkins the process of developing an identity is subject to both internal and 
external forces, meaning a person’s identity will change over time.  The process 
of developing identity is not just a philosophical exercise, it also has practical 
consequences.  Relating this theory to the findings of this study, participants in 
both highlighted that through their social position, drug use, mental health 
diagnosis, involvement with mental health services, imprisonment and other 
issues people with schizophrenia are often estranged from main stream society.  
Previous identities of being violent man or a psychiatric in-patient had changed 
but the identity gained by being a regular cannabis smoker gave them a 
consistent sense of identity.  Findings from both study 1 & 2 indicate that people 
with schizophrenia who use cannabis can develop a sense of belonging within a 
community where “everyone” used cannabis seemingly unconcerned with any 
social stigma that cannabis use may attract within wider mainstream society. 
Bruins et al (2016) in their study into the associations between physical and 
mental health concluded that cannabis use in people with severe mental illness 
is associated with lower body mass index, smaller waist circumference and lower 
diastolic blood pressure but a great impact from psychotic symptoms.  Hill & 
Weiss (2016) concluded that there were minimal health risks associated with 
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long term cannabis use but noted the long term mental health dangers of 
cannabis use, particularly if people start using cannabis at a young age (which 
the study 1 participants did).  Whilst the findings of these two papers support 
the study 1 participants’ inclinations that cannabis use was good for their 
physical health they also provide a mixed message regarding continued cannabis 
use.  Due to the complex picture of understanding and working with people with 
schizophrenia, who also use cannabis, there is a need to develop a specialised 
workforce who deliver this integrated care (Knickman et al, 2016). 
Limitations of Study 
The small size of the sample and the possible influence of ethnicity and gender 
between the researchers and participants in study 1 are highlighted as 
limitations.  However, the validity of the research lies in whether at the time of 
the interview the participants gave the impression that they were discussing the 
material in an honest and unguarded manner. 
The IPA for focus groups does not necessarily allow for disconfirming evidence ‒ 
people who did not agree with the majority view but did not say anything. The 
presence of team leaders may have resulted in some participants reluctant to 
express divergent opinions. This critique can be neither proved nor disproved. 
However, the clinicians gave the impression of talking openly and freely, no-one 
contradicted themselves nor was there incongruent body language. 
Conclusion 
This study provides greater depth to understanding cannabis use within the 
experience of men with a diagnosis of schizophrenia.  The service users perceived 
cannabis use as a means by which they could re-establish their identity that had 
been damaged as a result of diagnosis and the social consequences of diagnosis, 
and held cannabis in a degree of ‘reverence’ which appeared not given to crack 
cocaine or alcohol. All the service user participants viewed cannabis use as 
beneficial. Equally, the clinicians understood that drugs are a significant part of 
life for their service users. Whilst not encouraging the use, the clinicians took the 
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pragmatic approach that cannabis use was prevalent in the community that they 
served. 
This study adds different dimensions to the available literature in providing 
greater depth to the reasons why people with schizophrenia use substances, in 
particular cannabis.   
Relevance for clinical practice 
The relevance of this study to clinical practice is for nurses working with ‘dual 
diagnosis’ service users.  This study highlights the perceived benefits of cannabis 
use amongst seven men and also clinicians’ responses to cannabis use.  The 
contribution that this paper makes to the current body of literature is that whilst 
the negative consequences of cannabis use amongst people with schizophrenia 
are well established, there is limited research into the benefits of cannabis use 
that people with schizophrenia are experiencing.    Additionally, the cannabis 
use described by the study 1 participants contributed to their sense of identity 
and belonging, issues under explored in the literature.  Equally there are some, 
but not many studies, that investigate staff responses to dual diagnosis service 
users.  Additionally, the study also points to the issue of prolonged cannabis use 
in an ageing population, an under investigated area.   
In both this study and Clutterbuck et al (2009) the attitude taken by clinician’s 
stressed the importance of the need for individualised care and being highly 
client specific. Although focused on cannabis use, this study points to the 
importance of mental health nurses attending to the dual diagnosis and to carry 
out health education interventions in order to care for these people, mainly 
directed to coping strategies.  In addition, it shows the importance of assessing 
the consumption pattern of these substances.  By understanding the conceptions 
of people with schizophrenia about cannabis use, the nurse will better informed 
in planning more effective interventions 
